NPR reposts a ProPublica story quoting Jane Zhu, M.D., regarding “ghost networks” of mental health providers who may be listed in insurance plans but aren’t actually available to see patients. She says, “Verify, verify, verify. Accuracy in behavioral health provider directories is akin to a coin flip.”

The Wall Street Journal covers physician backlash against private equity firms acquiring physician practices. Jane Zhu, M.D., says, “Physicians are very protective of their autonomy and clinical decision making, and there is a fear that shifts in ownership may erode that freedom.”

OPB-Radio covers the Great Salt Lick, an annual auction in Baker City that has generated $212,000 for the Parkinson’s disease and movement disorders program at OHSU.

David Huang, M.D., is referenced in an Eye World story about the development of high-resolution diagnostic devices for eye health.

Radiology Business reports that a private equity-backed firm that provides teleradiology for urgent care centers is enhancing its services with artificial intelligence. Ron Boucher, M.D., says, “Adopting AI as a part of our teleradiology overread services helps augment the radiologists’ tasks by pinpointing suspect areas to focus on in an X-Ray, enabling quicker X-ray interpretations so clinics can treat patients more effectively and efficiently.”

The Telegraph cites recent OHSU research in a story about the benefits of color noise exposure for anxious students in class.

New OHSU research, led by Eric Roeland, M.D., showing promise in treatment of cachexia, which includes appetite loss, loss of muscle mass and decreased physical activity in patients undergoing cancer treatment. Roeland says, “All of our cancer treatment therapies have some side effects. But we haven’t seen any concerns with this study so far.”

OHSU research suggests initial placement of defibrillator pads could make a significant difference in returning spontaneous blood circulation for patients in cardiac arrest. Lead author Joshua Lupton, M.D., a cardiac arrest survivor, says, “The less time that you’re in cardiac arrest, the better. The longer your brain has low blood flow, the lower your chances of having a good outcome.”

Story about the FDA’s recent approval of a new blood test to detect colorectal cancer. David Lieberman, M.D., says, “Detecting circulating-free DNA associated with [colorectal cancer] in blood is a major scientific breakthrough. The ease of blood testing will appeal to patients and providers."

MD Edge interviews experts about the FDA’s recent approval of a new blood test to detect colorectal cancer. David Lieberman, M.D., says, “Detecting circulating-free DNA associated with [colorectal cancer] in blood is a major scientific breakthrough. The ease of blood testing will appeal to patients and providers.”